NCT01997099

Brief Summary

The purpose of this study is to describe the home healthcare organization ambulatory infusion pump programming workflow and the process that was followed to introduce the new CADD®-Solis VIP System to each home healthcare organization or facility. In addition, this study will characterize the overall clinician (Phase 1) and patient (Phase 2) ease of use and satisfaction with the CADD®-Solis VIP System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 27, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

November 5, 2015

Status Verified

November 1, 2015

Enrollment Period

1.9 years

First QC Date

November 18, 2013

Last Update Submit

November 4, 2015

Conditions

Keywords

Drug LibraryAmbulatory Infusion PumpMedication Safety SoftwareCADD®-Solis VIPPump ProgrammingHome Infusion Workflow

Outcome Measures

Primary Outcomes (8)

  • Protocol Library Creation

    Characterize the effort required to create a new drug protocol library

    2-6 weeks post-enrollment

  • Describe Library Protocols and Safety Limits Utilized

    Summarize the drug protocols that were created in the library and describe the soft and hard safety limits that were utilized

    2-6 weeks post-enrollment

  • Pump Programming Ease of Use

    Characterize the ease of use associated with programming the CADD®-Solis VIP pump

    Day 1 - Immediately post-enrollment

  • Pump Programming Errors

    Summarize and describe any possible programming errors

    Day 1 - Immediately post-enrollment

  • Patient Training and Pump Set-up

    Characterize the home health nurse perception of patient training and pump set-up within the home

    2-4 months post-enrollment

  • Characterize Training Time for the New Pump System

    Describe the training time associated with implementing a new ambulatory infusion pump in each step of a home healthcare organization's workflow

    2-4 months post-enrollment

  • Workflow Changes

    Characterize the workflow changes that need to be implemented at home healthcare organizations when adopting the CADD®-Solis VIP System

    2-4 months post-enrollment

  • Overall Patient/Caregiver Satisfaction with the Pump

    Assess the overall patient/personal caregiver satisfaction with the CADD®-Solis VIP pump

    5-7 Days Post-Enrollment

Secondary Outcomes (4)

  • Number of Alarms Reported

    5-7 Days Post-Enrollment

  • Alarm Troubleshooting

    5-7 Days Post-Enrollment

  • Pump Difficulties

    5-7 Days Post-Enrollment

  • Pump Ease of Use

    5-7 Days Post-Enrollment

Study Arms (5)

Library Creation

Individuals responsible for creating the drug library

Device: CADD™ Solis Medication Safety Software Administrator

Pump Programming

Individuals responsible for programming ambulatory infusion pumps

Device: CADD®-Solis VIP Pump

Home Implementation

Individuals responsible for implementing ambulatory infusion pumps in patients' homes

Device: CADD®-Solis VIP Pump

Workflow

Individual at the facility responsible for describing the workflow of processing and implementing an ambulatory infusion pump prior to and after introducing the CADD®-Solis VIP System.

Device: CADD®-Solis VIP PumpDevice: CADD™ Solis Medication Safety Software Administrator

Ambulatory Infusion Pump Patients

Patients that receive a prescription requiring use of the CADD®-Solis VIP pump

Device: CADD®-Solis VIP Pump

Interventions

Ambulatory Infusion Pump PatientsHome ImplementationPump ProgrammingWorkflow

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Home healthcare organizations that utilize ambulatory infusion pumps for their patients will be approached for participation in the study

You may qualify if:

  • Part 1: Licensed clinicians that would be responsible for protocol library creation at the center
  • Part 2: Individuals that are responsible for ambulatory infusion pump programming per the organization's standard operating procedure
  • Part 3: Licensed clinicians that are responsible for performing the pump set-up and implementation activities within the home setting
  • Part 4: Center personnel that are involved in the CADD®-Solis VIP System implementation process

You may not qualify if:

  • Individuals that are unwilling or unable to answer questions as required by the protocol
  • Phase 2
  • Patients 18 years of age or older
  • Patients prescribed a home infusion requiring use of the CADD®-Solis VIP pump
  • Patients with infusions prescribed for a minimum duration of five (5) days
  • Patient or patient's personal caregiver on behalf of the patient is willing and able to comply with the data collection requirements
  • Patient is willing and able to provide informed consent for study participation
  • Patient is currently enrolled or plans to enroll in a concurrent study that may confound the results of this study
  • Based upon a clinician's opinion, the patient has health conditions or a psychological/cognitive status that would preclude proper participation in the study and does not have a personal caregiver available to perform study activities on behalf of the patient
  • Previous use or experience with the CADD®-Solis VIP pump

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Big Sky IV Care

Kalispell, Montana, 59901, United States

Location

Thomas Jefferson University Hospital - Jefferson Home Infusion

Philadelphia, Pennsylvania, 19107, United States

Location

Study Officials

  • Thomas D Brown, MBA, PharmD

    Thomas Jefferson University Hospital - Jefferson Home Infusion

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2013

First Posted

November 27, 2013

Study Start

November 1, 2013

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

November 5, 2015

Record last verified: 2015-11

Locations